Literature DB >> 27852136

Generation of high-avidity, WT1-reactive CD8+ cytotoxic T cell clones with anti-leukemic activity by streptamer technology.

Antje Tunger1, Rebekka Wehner1,2, Malte von Bonin2,3,4,5, Denise Kühn6, Falk Heidenreich3, Sarah Matko7, Magdalena Nauerth8, Elke Rücker-Braun3, Sevina Dietz6, Cornelia S Link3,6, Anne Eugster6, Marcus Odendahl7, Dirk H Busch8, Torsten Tonn4,5,6,7, Ezio Bonifacio6, Lothar Germeroth9, Johannes Schetelig3, Michael P Bachmann2,4,5,6,10, Martin Bornhäuser2,3,4,5,6, Marc Schmitz1,2,4,5,6.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27852136     DOI: 10.1080/10428194.2016.1233538

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  4 in total

1.  Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8+ cytotoxic T cells.

Authors:  Falk Heidenreich; Elke Rücker-Braun; Juliane S Walz; Anne Eugster; Denise Kühn; Sevina Dietz; Annika Nelde; Antje Tunger; Rebekka Wehner; Cornelia S Link; Jan M Middeke; Friedrich Stölzel; Torsten Tonn; Stefan Stevanovic; Hans-Georg Rammensee; Ezio Bonifacio; Michael Bachmann; Matthias Zeis; Gerhard Ehninger; Martin Bornhäuser; Johannes Schetelig; Marc Schmitz
Journal:  Haematologica       Date:  2017-08-24       Impact factor: 9.941

2.  Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody.

Authors:  Christian Augsberger; Gerulf Hänel; Wei Xu; Vesna Pulko; Lydia Jasmin Hanisch; Angelique Augustin; John Challier; Katharina Hunt; Binje Vick; Pier Eduardo Rovatti; Christina Krupka; Maurine Rothe; Anne Schönle; Johannes Sam; Emmanuelle Lezan; Axel Ducret; Daniela Ortiz-Franyuti; Antje-Christine Walz; Jörg Benz; Alexander Bujotzek; Felix S Lichtenegger; Christian Gassner; Alejandro Carpy; Victor Lyamichev; Jigar Patel; Nikola Konstandin; Antje Tunger; Marc Schmitz; Michael von Bergwelt-Baildon; Karsten Spiekermann; Luca Vago; Irmela Jeremias; Estelle Marrer-Berger; Pablo Umaña; Christian Klein; Marion Subklewe
Journal:  Blood       Date:  2021-12-23       Impact factor: 25.476

3.  A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer.

Authors:  Hans-Georg Rammensee; Karl-Heinz Wiesmüller; P Anoop Chandran; Henning Zelba; Elisa Rusch; Cécile Gouttefangeas; Daniel J Kowalewski; Moreno Di Marco; Sebastian P Haen; Juliane S Walz; Yamel Cardona Gloria; Johanna Bödder; Jill-Marie Schertel; Antje Tunger; Luise Müller; Maximilian Kießler; Rebekka Wehner; Marc Schmitz; Meike Jakobi; Nicole Schneiderhan-Marra; Reinhild Klein; Karoline Laske; Kerstin Artzner; Linus Backert; Heiko Schuster; Johannes Schwenck; Alexander N R Weber; Bernd J Pichler; Manfred Kneilling; Christian la Fougère; Stephan Forchhammer; Gisela Metzler; Jürgen Bauer; Benjamin Weide; Wilfried Schippert; Stefan Stevanović; Markus W Löffler
Journal:  J Immunother Cancer       Date:  2019-11-15       Impact factor: 13.751

4.  Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141+ dendritic cells to activate naïve and memory WT1-specific CD8+ T cells.

Authors:  Frances E Pearson; Kirsteen M Tullett; Ingrid M Leal-Rojas; Oscar L Haigh; Kelly-Anne Masterman; Carina Walpole; John S Bridgeman; James E McLaren; Kristin Ladell; Kelly Miners; Sian Llewellyn-Lacey; David A Price; Antje Tunger; Marc Schmitz; John J Miles; Mireille H Lahoud; Kristen J Radford
Journal:  Clin Transl Immunology       Date:  2020-06-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.